Anti-Methicillin-resistant Staphylococcus aureus (MRSA) Antibody (15715)

Anti-Methicillin-resistant Staphylococcus aureus (MRSA) Antibody (15715)

Product No.: 15715

- -
- -
Clone
198
Target
Methicillin-resistant Staphylococcus aureus (MRSA)
Formats AvailableView All
Product Type
Monoclonal
Isotype
Mouse IgG1
Applications
IHC
,
WB

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Mrsa
Host Species
Mouse
Immunogen
Gel-purified MRSA protein from strain EMRSA 16
Formulation
Lyophilized purified antibody in PBS at a concentration of 1mg/ml.
State of Matter
Lyophilized
Product Preparation
Purified by immunoaffinity chromatography
Storage and Handling
This lyophilized product is stable for two years at 4°C. After reconstitution, store aliquots at -20°C.
Country of Origin
USA
Shipping
Next Day 2-8°C
Applications and Recommended Usage?
Quality Tested by Leinco
ELISA: use at a 1:5,000 dilution in direct ELISA against purified MRSA protein or MRSA-positive Staphylococcus aureus lysate

Immunoblotting: use at a 1:2,000 dilution. A band of approx. 70kDa is detected.

These are recommended dilutions.

End user should determine optimal dilutions for their applications.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
Mouse Monoclonal Antibody specific to Methicilin-resistant Staph aureus (MRSA)
Background
Methicillin-resistant Staphylococcus aureus (MRSA) survives treatment with broad-spectrum beta-lactam antibiotics including penicillin, methicillin, and cephalosporins. Previously, most MRSA infections occurred in hospitals or other health care settings, such as nursing homes and dialysis centers and were known as “health care-associated MRSA” or HA-MRSA. Older adults and people with weakened immune systems were most at risk of contracting HA-MRSA. More recently, another type of MRSA has occurred among otherwise healthy people in the wider community. This form, “community-associated MRSA”, or CA-MRSA, causes serious skin and soft tissue infections and a potentially lethal form of pneumonia.
Research Area
Infectious Disease

References & Citations

IHC
General Western Blot Protocol

Certificate of Analysis

Formats Available

Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.